Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
作者信息
Ehmsen Sidse, Asmussen Anders, Jeppesen Stefan S, Nilsson Anna Christine, Østerlev Sabina, Vestergaard Hanne, Justesen Ulrik S, Johansen Isik S, Frederiksen Henrik, Ditzel Henrik J
机构信息
Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark.
Department of Hematology, Odense University Hospital, Odense, Denmark.
出版信息
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
Abstract
摘要
相似文献
1
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
2
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
Mol Ther. 2021 Jun 2;29(6):1970-1983. doi: 10.1016/j.ymthe.2021.04.001. Epub 2021 Apr 5.
3
Could mixing COVID vaccines boost immune response?
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
4
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity. 2021 Aug 10;54(8):1869-1882.e6. doi: 10.1016/j.immuni.2021.06.018. Epub 2021 Jul 2.
5
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
Nat Commun. 2021 Feb 3;12(1):776. doi: 10.1038/s41467-021-21037-2.
6
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.
Cancer Cell. 2021 Nov 8;39(11):1445-1447. doi: 10.1016/j.ccell.2021.10.003. Epub 2021 Oct 12.
7
SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
Cell Mol Immunol. 2021 Aug;18(8):2040-2041. doi: 10.1038/s41423-021-00730-8. Epub 2021 Jul 15.
8
SARS-CoV-2 evolution and vaccines: cause for concern?
Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.
9
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.
Nat Commun. 2021 May 17;12(1):2893. doi: 10.1038/s41467-021-23173-1.
10
Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.
Ann Rheum Dis. 2021 Oct;80(10):e162. doi: 10.1136/annrheumdis-2021-220756. Epub 2021 Jul 16.
引用本文的文献
1
Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters.
Front Immunol. 2025 Aug 12;16:1629473. doi: 10.3389/fimmu.2025.1629473. eCollection 2025.
2
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapies.
Res Sq. 2025 Jul 4:rs.3.rs-7016519. doi: 10.21203/rs.3.rs-7016519/v1.
3
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.
Ther Adv Med Oncol. 2025 May 17;17:17588359251316224. doi: 10.1177/17588359251316224. eCollection 2025.
4
SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy.
Front Immunol. 2024 Dec 18;15:1510942. doi: 10.3389/fimmu.2024.1510942. eCollection 2024.
5
COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19.
Curr Oncol. 2024 Sep 10;31(9):5330-5343. doi: 10.3390/curroncol31090393.
6
Low booster uptake in cancer patients despite health benefits.
iScience. 2024 Jul 26;27(9):110596. doi: 10.1016/j.isci.2024.110596. eCollection 2024 Sep 20.
7
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.
Front Immunol. 2024 Aug 27;15:1447555. doi: 10.3389/fimmu.2024.1447555. eCollection 2024.
8
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients.
Vaccines (Basel). 2024 Jul 28;12(8):848. doi: 10.3390/vaccines12080848.
9
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2357424. doi: 10.1080/21645515.2024.2357424. Epub 2024 May 24.
10
Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation.
Vaccines (Basel). 2024 Mar 6;12(3):275. doi: 10.3390/vaccines12030275.
本文引用的文献
1
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
2
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
3
WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
Lancet. 2021 Apr 10;397(10282):1347-1348. doi: 10.1016/S0140-6736(21)00527-4. Epub 2021 Mar 23.
4
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.
Acta Oncol. 2021 Jul;60(7):859-865. doi: 10.1080/0284186X.2021.1889659. Epub 2021 Mar 1.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
COVID-19 and Cancer: Current Challenges and Perspectives.
Cancer Cell. 2020 Nov 9;38(5):629-646. doi: 10.1016/j.ccell.2020.09.018. Epub 2020 Oct 1.
7
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12.
8
Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer.
Breast Cancer Res. 2016 Jan 26;18(1):10. doi: 10.1186/s13058-015-0669-x.
9
Trends in cancer in the elderly population in Denmark, 1980-2012.
Acta Oncol. 2016;55 Suppl 1:1-6. doi: 10.3109/0284186X.2015.1114678. Epub 2016 Jan 19.
Zotero 插件